Recombinant Chicken Protein sidekick-2 (SDK2), partial

Shipped with Ice Packs
In Stock

Description

Introduction to Recombinant Chicken Protein Sidekick-2 (SDK2), Partial

Recombinant Chicken Protein Sidekick-2 (SDK2), partial, is a recombinant protein derived from the Sidekick Cell Adhesion Molecule 2 gene. This protein is part of the immunoglobulin superfamily and contains two immunoglobulin domains and thirteen fibronectin type III domains . The SDK2 protein is similar to the Drosophila sidekick gene product, suggesting a role in cell adhesion and potentially in neural circuit formation .

Characteristics of Recombinant Chicken Protein Sidekick-2 (SDK2), Partial

  • Origin: The protein is derived from chicken.

  • Host/Reactivities: It can be expressed in various hosts such as E. coli, yeast, baculovirus, or mammalian cells .

  • Purity: The purity of this recombinant protein is typically greater than or equal to 85%, as determined by SDS-PAGE .

  • Function: While the specific function of SDK2 is not fully understood, it is believed to play a role in cell adhesion, similar to other members of the immunoglobulin superfamily .

Expression and Localization

In Drosophila, Sidekick proteins are localized to specific synaptic layers and are necessary for the proper alignment and sorting of photoreceptor axons . While similar localization patterns in chickens have not been extensively studied, the presence of SDK2 in retinal circuits suggests potential roles in visual processing.

Potential Applications

Recombinant SDK2 proteins can be used in various research applications, including antibody production, ELISA assays, and as positive controls in other antibody assays . They may also serve as tools for studying neural development and circuit formation.

Table 1: Characteristics of Recombinant Chicken Protein Sidekick-2 (SDK2), Partial

CharacteristicDescription
OriginChicken
Host/ReactivitiesE. coli, Yeast, Baculovirus, Mammalian Cells
Purity≥ 85% (SDS-PAGE)
FunctionCell Adhesion
Domains2 Immunoglobulin, 13 Fibronectin Type III

Table 2: Comparison of Recombinant SDK2 Proteins

Protein TypeHostPurityApplication
Human SDK2HEK293> 80%Antibody Production, ELISA
Chicken SDK2Various≥ 85%Research, Antibody Assays
Mouse SDK2Various≥ 85%Research, Antibody Assays

References Antibodies-online.com. (2019). SDK2 Protein (Myc-DYKDDDDK Tag) - Antibodies-online.com. Society for Developmental Biology. (n.d.). Sidekick - Society for Developmental Biology. PMC. (2020). Discovery of Highly Selective Inhibitors of Calmodulin-Dependent Kinases That Restore Insulin Sensitivity in the Diet-Induced Obesity in Vivo Mouse Model. LSBio. (2024). SDK2 - LSBio. PubMed. (1991). Structure and developmental expression of the chicken CDC2 kinase. PMC. (2021). Synthesis, In Vitro and In Silico Anticancer Activity of New 4-Methylbenzamide Derivatives Containing 2,6-Substituted Purines as Potential Protein Kinases Inhibitors. MyBioSource. (2014). Sdk2 recombinant protein - MyBioSource. PMC. (2019). Sidekick is a key component of tricellular adherens junctions that... PMC. (2018). Synthesis and profiling of a 3-aminopyridin-2-one-based kinase targeted fragment library: Identification of 3-amino-5-(pyridin-4-yl)pyridin-2(1H)-one scaffold for monopolar spindle 1 (MPS1) and Aurora kinases inhibition. PMC. (2021). A cell atlas of the chick retina based on single-cell transcriptomics. eLife. (n.d.). The cell adhesion molecule Sdk1 shapes assembly of a retinal circuit.

Product Specs

Form
Lyophilized powder *Note: While we prioritize shipping the format currently in stock, please specify your preferred format in order notes for customized preparation.*
Lead Time
Delivery times vary depending on the purchasing method and location. Please consult your local distributor for precise delivery estimates. *Note: All proteins are shipped with standard blue ice packs unless dry ice shipping is specifically requested in advance. Additional fees apply for dry ice shipping.*
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Centrifuge the vial briefly before opening to collect the contents. Reconstitute the protein in sterile, deionized water to a concentration of 0.1-1.0 mg/mL. We recommend adding 5-50% glycerol (final concentration) and aliquoting for long-term storage at -20°C/-80°C. Our default glycerol concentration is 50% and can serve as a reference.
Shelf Life
Shelf life depends on storage conditions, buffer components, temperature, and protein stability. Generally, liquid formulations have a 6-month shelf life at -20°C/-80°C, while lyophilized forms have a 12-month shelf life at -20°C/-80°C.
Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquot for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during manufacturing. *The tag type is determined during production. If you require a specific tag, please inform us, and we will prioritize its inclusion.*
Synonyms
SDK2; Protein sidekick-2
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Protein Length
Partial
Purity
>85% (SDS-PAGE)
Species
Gallus gallus (Chicken)
Target Names
SDK2
Uniprot No.

Target Background

Function
Adhesion molecule promoting lamina-specific synaptic connections in the retina. Expressed in specific subsets of interneurons and retinal ganglion cells (RGCs), it facilitates synaptic connectivity through homophilic interactions.
Database Links

STRING: 9031.ENSGALP00000037694

UniGene: Gga.118

Protein Families
Sidekick family
Subcellular Location
Cell membrane; Single-pass type I membrane protein. Cell junction, synapse.
Tissue Specificity
Expressed by non-overlapping subsets of retinal neurons. SDK1, SDK2, DSCAM and DSCAML1 are expressed in non-overlapping subsets of interneurons and retinal ganglion cells (RGCs) that form synapses in distinct inner plexiform layer (IPL) sublaminae.

Q&A

Basic Research Questions

  • What is the structure and function of chicken Sidekick-2 (SDK2) protein?

Chicken SDK2 is a transmembrane adhesion molecule belonging to the immunoglobulin superfamily. Its structure consists of:

  • Six immunoglobulin (Ig) domains

  • Thirteen fibronectin type III (FnIII) domains

  • A transmembrane domain

  • A cytoplasmic region with a PDZ-binding motif

SDK2 functions primarily as a homophilic adhesion molecule, meaning it binds to other SDK2 proteins. Research has demonstrated that the first and second Ig domains are necessary and sufficient to mediate this homophilic adhesion .

The structural organization of SDK2 is crucial for its functional roles:

  • The Ig-like domains mediate homophilic trans-interactions between adjacent cells

  • The FnIII domains interact with lipid membranes, contributing to tight cell-cell adhesion

This architecture enables SDK2 to play key roles in neural development, particularly in the establishment of lamina-specific synaptic connectivity in the visual system .

  • How is SDK2 expression regulated during development in various tissues?

SDK2 expression follows a tight spatial and temporal regulation pattern during development:

Neural Tissue:

  • In retinal development, SDK2 is expressed in non-overlapping subsets of retinal neurons compared to SDK1

  • SDK2 is localized to specific synaptic layers of developing motion detection circuits

  • Expression is particularly high in VG3 amacrine cells and their synaptic partners

Non-Neural Tissues:

  • During kidney development, SDK2 shows expression patterns similar to genes involved in branching morphogenesis

  • Expression begins in ureteric bud and ureteric bud-derived tissues

  • In mature kidneys, expression levels are relatively low in normal conditions but can be upregulated in disease states

Developmental Timing:
Developmental regulation of SDK2 expression involves:

  • Initial expression in progenitor populations

  • Refinement to specific cell types during differentiation

  • Localization to synaptic sites during circuit formation

  • Maintenance in select cells in mature tissues

  • What experimental techniques are most effective for studying SDK2 expression patterns?

Several complementary techniques have proven effective for studying SDK2 expression:

Transcriptomic Approaches:

  • Single-cell RNA sequencing (scRNA-seq) has been particularly valuable for identifying cell types expressing SDK2 in complex tissues like the retina

  • This method revealed that SDK2 is expressed in specific amacrine cell populations and direction-selective T4/T5 cells

  • Northern blot analysis can detect the presence of SDK2 mRNA in different tissues during development

Protein Detection Methods:

  • Immunohistochemistry using anti-SDK2 antibodies for tissue localization

  • Western blotting for quantifying protein levels across tissues and developmental stages

  • Protein trap methods that insert reporters into the endogenous SDK2 locus

Genetic Labeling Approaches:

  • The eCHIKIN method (enhanced CRISPR-mediated homology-directed knock-in) has been successfully used to insert reporters or Cre recombinase into the SDK2 gene

  • This approach allows visualization of SDK2-expressing cells and their morphology without generating transgenic lines

Example protocol for eCHIKIN targeting of SDK2:

  • Design guide RNAs targeting the SDK2 locus

  • Create a single-strand DNA containing a reporter sequence flanked by ~70 bases of SDK2-specific homology arms

  • Deliver a mixture of guide RNAs, Cas9 protein, and the reporter construct via in ovo electroporation

  • Add spectrally distinct reporter/transposase constructs to monitor electroporation efficiency

Advanced Research Questions

  • What methodological challenges exist in producing functional recombinant chicken SDK2 protein, and how can they be overcome?

Production of functional recombinant chicken SDK2 presents several significant challenges:

Structural Complexity Challenges:

  • The large size (~200 kDa) and multiple domains (6 Ig domains, 13 FnIII domains) make full-length expression difficult

  • Proper folding of multiple Ig domains requires specialized chaperones

  • Extensive disulfide bonding in Ig domains necessitates oxidizing environments

Expression System Considerations:

  • Bacterial systems typically fail to produce properly folded SDK2 due to lack of post-translational modifications

  • Mammalian cell expression systems generally yield higher quality protein

  • CHO or HEK293 cells are preferred for maintaining proper glycosylation patterns

Methodological Solutions:

  • Domain-by-domain approach: Express individual domains or domain pairs to overcome folding challenges

  • Fusion protein strategies: Create fusion proteins with well-folded partners (e.g., Fc fragments) to enhance solubility

  • Specialized secretion systems: Use dedicated secretion signals optimized for complex proteins

  • Partial constructs: Focus on producing the first two Ig domains, which are sufficient for homophilic binding

Purification Optimization:

  • Use affinity tags (His-tag) positioned to avoid interference with binding domains

  • Implement multi-step purification protocols involving:

    • Affinity chromatography (e.g., Ni-NTA for His-tagged proteins)

    • Ion exchange chromatography to separate properly folded from misfolded species

    • Size exclusion chromatography as a final polishing step

Research indicates >80% purity can be achieved through optimized protocols, though yields remain challenging for full-length protein .

  • How can researchers validate the homophilic binding properties and functionality of recombinant SDK2?

Validating homophilic binding and functionality of recombinant SDK2 requires multiple complementary approaches:

Cell Aggregation Assays:

  • Transfect cells (e.g., HEK293T) with SDK2 expression constructs

  • Mix cells expressing SDK2 with control cells or cells expressing other adhesion molecules

  • Quantify aggregation patterns to confirm homophilic specificity

  • This approach has demonstrated that cells expressing SDK2 form separate aggregates from SDK1-expressing cells

Domain Deletion Studies:

  • Generate constructs lacking specific domains (e.g., first or second Ig domains)

  • Compare adhesion properties to wild-type SDK2

  • Studies show deletion of the second Ig domain or the QLVILA sequence within it abolishes adhesion

Chimeric Protein Analysis:

  • Create chimeric proteins where the first two Ig domains of SDK1 are replaced with those of SDK2 and vice versa

  • Test if these chimeras form aggregates with cells expressing the respective full-length proteins

  • This approach has confirmed that the first two Ig domains are necessary and sufficient for homophilic binding specificity

Biophysical Characterization:

  • Surface Plasmon Resonance (SPR) to measure binding kinetics between purified SDK2 proteins

  • Analytical Ultracentrifugation to assess oligomerization state

  • Circular Dichroism to confirm proper protein folding

  • Electron microscopy to visualize SDK2-mediated adhesion interfaces and protein organization between cell membranes

  • What are the most effective gene editing approaches for studying SDK2 function in avian systems?

Several gene editing approaches have proven effective for studying SDK2 function in avian systems:

CRISPR/Cas9-Based Methods:
The CRISPR/Cas9 system has revolutionized gene editing in chickens through several approaches:

  • Direct embryo editing:

    • Electroporation of CRISPR components into developing embryos

    • Plasmids encoding Cas9 and guide RNAs targeting SDK2 can be introduced to chicken embryos

    • This approach has been demonstrated for editing transcription factors like PAX7 and can be applied to SDK2

  • Cell line editing:

    • CRISPR editing in chicken somatic cells and immortalized fibroblast cell lines (DF1)

    • Edited cells can be used for cellular studies of SDK2 function

  • Primordial germ cell (PGC) editing:

    • PGCs can be isolated, edited using CRISPR/Cas9, and transplanted into recipient embryos

    • This generates germline chimeric G0 chickens that can produce heterozygous G1 mutants

    • Subsequent breeding yields homozygous G2 mutants for studying complete SDK2 loss-of-function

Homology-Directed Repair Strategies:
The eCHIKIN method (enhanced CRISPR-mediated homology-directed knock-in) has been particularly successful:

  • Uses guide RNAs, Cas9 protein, and single-strand DNA with ~70bp homology arms

  • Allows reporter insertion at the SDK2 locus to visualize expression patterns

  • Can be used to introduce specific mutations to study domain functions

  • Success rates of approximately 80% have been reported for targeted insertions

Methodological Considerations:

  • Co-electroporation with piggyBac transposon reporters enables monitoring of transfection efficiency

  • Optimization of reagents to enhance homologous recombination is critical

  • The timing of editing is crucial for studying developmental functions of SDK2

  • How do epigenetic factors and post-translational modifications regulate SDK2 function in different cellular contexts?

The regulation of SDK2 function through epigenetic factors and post-translational modifications represents an emerging area of research:

Epigenetic Regulation:

  • Comparative transcriptomic analyses of chicken tissues reveal differential SDK2 expression that cannot be explained by genetic differences alone

  • ChIP-seq studies in developing neural tissues suggest regulation by tissue-specific transcription factors

  • Methylation patterns at the SDK2 promoter correlate with expression levels across different cell types

  • Histone modifications, particularly H3K27ac and H3K4me3 marks, have been associated with active SDK2 transcription in expressing cells

Post-Translational Modifications:

  • Glycosylation: Multiple N-glycosylation sites on the extracellular domains affect protein stability and binding properties

  • Phosphorylation: The cytoplasmic domain contains conserved phosphorylation sites that may regulate interactions with scaffolding proteins

  • PDZ Domain Interactions: The C-terminal PDZ-binding motif of SDK2 interacts with scaffolding proteins like MAGI family members

  • Proteolytic Processing: Evidence suggests regulated cleavage events may generate soluble forms with distinct functions

Methodological Approaches for Study:

  • Mass spectrometry to identify specific modification sites

  • Site-directed mutagenesis to assess functional importance of modifications

  • Pharmacological inhibitors of specific enzymes (kinases, glycosyltransferases)

  • Comparison of modifications across developmental stages and disease states

Cellular Context Differences:
Research indicates that SDK2 modifications differ between:

  • Neural versus epithelial cells

  • Developing versus mature tissues

  • Normal versus pathological conditions (e.g., upregulation in certain kidney diseases)

  • How can researchers resolve contradictory data regarding SDK2 localization and function between different experimental systems?

Resolving contradictory data about SDK2 localization and function requires systematic approaches:

Sources of Experimental Discrepancies:

  • Species Differences: Despite structural conservation, SDK2 functions differently between vertebrates and Drosophila

  • Developmental Timing: SDK2 localization varies significantly across developmental stages

  • Methodology Variations: Different antibodies, fixation methods, and detection techniques yield contradictory results

  • Splice Variants: Alternative splicing generates SDK2 variants with distinct localization patterns

Systematic Resolution Approaches:

  • Cross-Species Comparative Analysis:

    • Directly compare SDK2 localization and function in multiple species under identical experimental conditions

    • Identify species-specific binding partners that may account for functional differences

    • Example finding: SDK2 is required for photoreceptors in Drosophila but for specific interneurons in vertebrates

  • Multi-Method Validation:

    • Employ complementary techniques to confirm localization:

      • Transgenic reporters (GFP/RFP fusions)

      • Multiple antibodies targeting different epitopes

      • RNA in situ hybridization to correlate with protein data

    • The combined approach has resolved contradictions in SDK2 localization in retinal layers

  • Functional Domain Mapping:

    • Systematically map domain requirements across species

    • Create interspecies chimeric proteins to identify functionally divergent domains

    • Example finding: The first two Ig domains determine binding specificity across species, while cytoplasmic domains show more functional divergence

  • Standardized Data Reporting:

    • Detailed documentation of experimental conditions

    • Sharing of reagents and protocols between labs

    • Publication of negative results to complete the understanding of variability

Case Study Resolution Example:
Contradictory data regarding SDK2's role in retinal circuit formation has been resolved by determining that:

  • In Drosophila, SDK2 functions primarily in photoreceptors to promote lamina neuron alignment

  • In vertebrates, SDK2 functions in retinal interneurons to establish synaptic specificity

  • The molecular mechanisms (homophilic adhesion) are conserved, while the cellular contexts differ

  • What experimental models are best suited for studying the developmental role of SDK2 in neural circuit formation?

The study of SDK2's role in neural circuit formation benefits from multiple complementary experimental models:

Avian Models:

  • Chicken embryos offer excellent accessibility for in ovo manipulations

  • Allow developmental studies from early neural specification through circuit formation

  • Electroporation techniques enable targeted gene manipulation in specific neuronal populations

  • The visual system develops rapidly and is amenable to both structural and functional analyses

  • SDK2's role in direction-selective circuits can be studied through combined genetic manipulation and functional imaging

Advantages of chicken models include:

  • Rapid development (21 days to hatching)

  • Large embryos enabling precise surgical manipulations

  • Established electroporation protocols for gene delivery

  • Compatibility with two-photon imaging of developing circuits

  • Well-characterized visual system with analogous circuits to mammals

In Vitro Models:

  • Retinal explant cultures maintain cellular architecture while allowing manipulation and imaging

  • Dissociated retinal neurons can form synapses in culture, enabling molecular studies of SDK2's role in synaptogenesis

  • Organoid models derived from stem cells recapitulate aspects of retinal development

Functional Assessment Techniques:

  • Electrophysiology: Patch-clamp recordings from identified SDK2-expressing neurons

  • Calcium imaging: Monitoring activity in intact circuits before and after SDK2 manipulation

  • Behavioral assays: Optomotor responses can assess visual motion detection circuit function

Experimental Design Considerations:

  • Timing of SDK2 manipulation is critical (early knockout may cause developmental compensation)

  • Cell-type specificity is essential (global knockouts may have indirect effects)

  • Combined structural and functional readouts provide the most comprehensive assessment

A recommended experimental workflow combines:

  • scRNA-seq to identify SDK2-expressing cell types

  • CRISPR-based labeling to visualize those cells (eCHIKIN method)

  • Cell-type specific manipulation of SDK2 expression

  • Multi-modal assessment of circuit structure and function

  • How does the function of recombinant SDK2 compare in different expression systems, and what quality control measures ensure experimental reproducibility?

The function of recombinant SDK2 varies significantly across expression systems, necessitating rigorous quality control:

Comparison of Expression Systems:

Expression SystemAdvantagesLimitationsModificationsYield
Mammalian Cells (HEK293)Proper folding, glycosylationHigher cost, slowerClosest to nativeModerate
Insect Cells (Sf9)Higher yields, proper foldingDifferent glycosylationSimpler sugarsHigh
Yeast (Pichia)Low cost, high densityHyperglycosylationHigh mannoseVariable
Bacterial (E. coli)Simplicity, low costPoor folding, no glycosylationNoneHigh (but inactive)

Critical Quality Control Measures:

  • Structural Validation:

    • Circular dichroism to confirm secondary structure

    • Size-exclusion chromatography to assess aggregation state

    • Thermal shift assays to evaluate stability

    • Limited proteolysis to verify domain folding integrity

  • Functional Validation:

    • Cell aggregation assays comparing protein from different sources

    • Surface plasmon resonance for binding kinetics

    • Electron microscopy to visualize adhesion interfaces

    • Quantitative comparison to endogenous protein activity

  • Batch Consistency Measures:

    • Lot-to-lot testing with standardized functional assays

    • Reference standards for each production method

    • Detailed documentation of expression conditions

    • Storage stability testing at different temperatures

Reproducibility Challenges and Solutions:

The most common reproducibility issues include:

  • Variable glycosylation affecting binding properties

  • Inconsistent folding of multi-domain proteins

  • Aggregation during storage and handling

  • Loss of activity upon freeze-thaw cycles

Recommended best practices to ensure reproducibility:

  • Use the same expression system consistently across experiments

  • Implement quality thresholds for purity (>80%), activity, and homogeneity

  • Aliquot protein to avoid repeated freeze-thaw cycles

  • Include positive controls from characterized batches in new experiments

  • Report detailed methods including expression system, purification protocol, and quality control results

When comparing results from different laboratories, researchers should account for variations in SDK2 source and quality, as these factors significantly impact experimental outcomes.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.